Maryland Capital Management’s PURE BIOSCIENCE INC COM STK NEW (DE) PURE Stock Holding History

Maryland Capital Management’s Portfolio PURE Stock Details PURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-56,231	Closed	-$17K	–	198
2019 Q3	$17K	Buy	56,231 +5,000	+10%	+$1.51K	﹤0.01%	198
2019 Q2	$20K	Hold	51,231	–	–	﹤0.01%	182
2019 Q1	$25K	Buy	51,231 +2,577	+5%	+$1.26K	﹤0.01%	177
2018 Q4	$18K	Buy	48,654 +31,154	+178%	+$11.5K	﹤0.01%	173
2018 Q3	$9K	Buy	17,500 +5,000	+40%	+$2.57K	﹤0.01%	168
2018 Q2	$8K	Buy	+12,500	New	+$8K	﹤0.01%	168

Maryland Capital Management's PURE Position: Q4 2019 in Review

Maryland Capital Management sold out of PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) in Q4 2019, closing a stake of 56,231 shares — an estimated $17K sold.

Maryland Capital Management first reported a position in PURE in Q2 2018 and held it in 6 quarters. The position peaked at $25K in Q1 2019. 0 funds tracked by Wall St. Rank hold PURE as of Q4 2019.

Maryland Capital Management reported no remaining PURE BIOSCIENCE INC COM STK NEW (DE) position as of Q4 2019 after selling out during the quarter.
Maryland Capital Management sold 56,231 PURE BIOSCIENCE INC COM STK NEW (DE) shares in Q4 2019, an estimated $17K.
Maryland Capital Management first reported a position in PURE BIOSCIENCE INC COM STK NEW (DE) in Q2 2018 and held it in 6 quarters.
Maryland Capital Management's PURE BIOSCIENCE INC COM STK NEW (DE) position peaked at $25K in Q1 2019.
0 funds tracked by Wall St. Rank held PURE BIOSCIENCE INC COM STK NEW (DE) as of Q4 2019.

Based on Maryland Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.